國立高雄大學圖資館 |

Language: English

Back

Safety pharmacology in pharmaceutica...

Gad, Shayne C., (1948-)

Safety pharmacology in pharmaceutical developmentapproval and post marketing surveillance /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Safety pharmacology in pharmaceutical developmentShayne C. Gad.
Reminder of title:	approval and post marketing surveillance /
Author:	Gad, Shayne C.,
other author:	Gad, Shayne C.,
Published:	Boca Raton, FL :CRC Press,c2012.
Description:	1 online resource (xv, 197 p.) :ill.
Notes:	Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.
Subject:	DrugsToxicology.
Online resource:	http://www.crcnetbase.com/isbn/9781439845684
ISBN:	9781439845684 (electronic bk.)

Safety pharmacology in pharmaceutical developmentapproval and post marketing surveillance /
Gad, Shayne C.,1948-

Safety pharmacology in pharmaceutical developmentapproval and post marketing surveillance /[electronic resource] :Shayne C. Gad. - 2nd ed. - Boca Raton, FL :CRC Press,c2012. - 1 online resource (xv, 197 p.) :ill.

Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.

Includes bibliographical references and index.

Safety pharmacology: background, history, issues and concerns -- Regulatory requirements: ICH, FDA, EMA, and Japan -- Principles of screening and study design -- Cardiovascular system -- Central nervous system -- Respiratory system -- Renal function -- Gastrointestinal system -- Immune system.

"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.

ISBN: 9781439845684 (electronic bk.)

LCCN: 2012009446Subjects--Topical Terms:

224656
Drugs
--Toxicology.

LC Class. No.: RA1238 / .G333 2012

Dewey Class. No.: 615.7/04

National Library of Medicine Call No.: 2012 F-386

Safety pharmacology in pharmaceutical developmentapproval and post marketing surveillance /
LDR:02030cmm a2200325 a 4500 001 486033
003 OCoLC
005 20121015081754.0
006 m o d
007 cr |n|---|||||
008 161104s2012 flua ob 001 0 eng
010 $a 2012009446
020 $a 9781439845684 (electronic bk.)
020 $z 9781439845677 (hardback)
035 $a (OCoLC)761380929
035 $a 761380929
040 $a DNLM/DLC $b eng $c DLC $d YDX $d NLM $d UKMGB $d YDXCP $d OCLCO $d ZWZ $d CDX $d MXC
050 4 $a RA1238 $b .G333 2012
060 0 0 $a 2012 F-386
060 1 0 $a QV 771
082 0 0 $a 615.7/04 $2 23
100 1 $a Gad, Shayne C., $d 1948- $3 225998
245 1 0 $a Safety pharmacology in pharmaceutical development $h [electronic resource] : $b approval and post marketing surveillance / $c Shayne C. Gad.
250 $a 2nd ed.
260 $a Boca Raton, FL : $b CRC Press, $c c2012.
300 $a 1 online resource (xv, 197 p.) : $b ill.
500 $a Rev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.
504 $a Includes bibliographical references and index.
505 0 $a Safety pharmacology: background, history, issues and concerns -- Regulatory requirements: ICH, FDA, EMA, and Japan -- Principles of screening and study design -- Cardiovascular system -- Central nervous system -- Respiratory system -- Renal function -- Gastrointestinal system -- Immune system.
520 $a "This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.
588 $a Description based on print version record.
650 0 $a Drugs $x Toxicology. $3 224656
650 0 $a Drugs $x Safety measures. $3 302362
650 0 $a Drug development $x Safety measures. $3 743595
650 1 2 $a Drug Evaluation, Preclinical. $3 226663
650 2 2 $a Drug Approval. $3 226662
650 2 2 $a Product Surveillance, Postmarketing. $3 265485
650 2 2 $a Toxicity Tests. $3 301938
700 1 $a Gad, Shayne C., $d 1948- $3 225998
856 4 0 $u http://www.crcnetbase.com/isbn/9781439845684